Beta Bionics (BBNX) Accounts Payables (2023 - 2026)

Beta Bionics has disclosed Accounts Payables across 4 years of filings, most recently posting $5.4 million for Q2 2026.

• In Q2 2026, Accounts Payables rose 56.28% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (up 56.28% YoY), while the FY2025 annual figure was $5.0 million, up 75.25% from the prior year.
• Accounts Payables came in at $5.4 million for Q2 2026 at Beta Bionics, up from $2.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $5.4 million in Q2 2026 to a low of $1.2 million in Q4 2023.
• Average Accounts Payables over 4 years is $3.5 million, with a median of $3.4 million recorded in 2025.
• Year-over-year, Accounts Payables surged 144.6% in 2024 and tumbled 32.89% in 2026.
• Over 4 years, Accounts Payables stood at $1.2 million in 2023, then jumped by 144.6% to $2.9 million in 2024, then surged by 75.25% to $5.0 million in 2025, then gained by 7.06% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $5.4 million in Q2 2026, $2.3 million in Q1 2026, and $5.0 million in Q4 2025.